284 related articles for article (PubMed ID: 25188362)
1. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
2. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
[TBL] [Abstract][Full Text] [Related]
6. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
[TBL] [Abstract][Full Text] [Related]
7. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
[TBL] [Abstract][Full Text] [Related]
8. Herpes Labialis: An Update.
Leung AKC; Barankin B
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
[TBL] [Abstract][Full Text] [Related]
9. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
[TBL] [Abstract][Full Text] [Related]
10. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
11. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
12. Failure of acyclovir cream in treatment of recurrent herpes labialis.
Shaw M; King M; Best JM; Banatvala JE; Gibson JR; Klaber MR
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):7-9. PubMed ID: 3926067
[TBL] [Abstract][Full Text] [Related]
13. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir Lauriad(®): a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis.
Downing C; Moayyad J; Tamirisa A; Tyring S
Expert Rev Anti Infect Ther; 2014 Mar; 12(3):283-7. PubMed ID: 24456534
[TBL] [Abstract][Full Text] [Related]
15. Thermographic resolution of the prodromal phase of herpes labialis treated with acyclovir.
Lamey PJ; Biagioni PA
Dentomaxillofac Radiol; 1995 Aug; 24(3):201-3. PubMed ID: 8617397
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for herpes labialis, I: Oral agents.
Elish D; Singh F; Weinberg JM
Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
[TBL] [Abstract][Full Text] [Related]
17. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
Kinghorn GR
Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
[TBL] [Abstract][Full Text] [Related]
18. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
19. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
Harmenberg J; Oberg B; Spruance S
Acta Derm Venereol; 2010 Mar; 90(2):122-30. PubMed ID: 20169294
[TBL] [Abstract][Full Text] [Related]
20. Herpes labialis.
Worrall G
Clin Evid; 2002 Jun; (7):1513-8. PubMed ID: 12230767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
